Society for Vascular Surgery: Acute Superior Mesenteric Venous Thrombosis Results in High Rates of Readmission and Morbidity
September 02, 2020
September 02, 2020
ROSEMONT, Illinois, Sept. 2 -- The Society for Vascular Surgery issued the following news release:
The largest single-institution study of acute mesenteric venous thrombosis unveils risk factors for bowel loss as well as patient condition one year after treatment. The study results were reported in the September edition of the Journal of Vascular Surgery: Venous and Lymphatic Disorders.
"Acute mesenteric venous thrombosis (MVT) is a rare and poorly understood entit . . .
The largest single-institution study of acute mesenteric venous thrombosis unveils risk factors for bowel loss as well as patient condition one year after treatment. The study results were reported in the September edition of the Journal of Vascular Surgery: Venous and Lymphatic Disorders.
"Acute mesenteric venous thrombosis (MVT) is a rare and poorly understood entit . . .